Breaking the Henipavirus Barrier: A Breakthrough Antibody Cocktail Against Nipah and Hendra Viruses
In the ongoing global effort to fortify defenses against emerging zoonotic threats, a team of researchers at the Icahn School...
Bioinformatics and Health Tech
Breakthrough in Bladder Cancer: Engineering a New Future for Organ-Sparing Immunotherapy
In a significant stride for oncology, researchers from Weill Cornell Medicine and the Roswell Park Comprehensive Cancer Center have unveiled...
Bionyra Pharma Emerges from Stealth with $165M Series A to Redefine Immunology
In a significant move that underscores the continued investor appetite for high-precision immunology, Bionyra Pharma has officially emerged from stealth...
Beyond the Breakthrough: Navigating the Complex Frontier of Clinical Genome Editing
CRISPR has evolved from a laboratory curiosity into a household term, fundamentally altering our perception of genetic medicine. With high-profile...
Next-Generation T-Cell Therapies: Circio and Tcelltech Forge Strategic Alliance to Revolutionize In Vivo Gene Delivery
In a move poised to reshape the landscape of immuno-oncology, Norway-based biotech firm Circio and German precision engineering company Tcelltech...
The Bacterial Brotherhood: New Research Reveals How Microbes Collaborate to Evade Antibiotics
In the ongoing evolutionary arms race between human medicine and pathogenic bacteria, scientists have long operated under the assumption that...
AI-Powered Precision: A Paradigm Shift in the Search for Solid Tumor CAR T Targets
The landscape of oncology is on the precipice of a seismic shift. For over a decade, Chimeric Antigen Receptor (CAR)...
Biotech at the Crossroads: John Crowley’s Blueprint for a New Era of Innovation
SAN DIEGO — The biotechnology industry stands at a pivotal historical inflection point. As the 2026 BIO International Convention draws...
Strategic Synergy: Lonza and InduPro Forge Partnership to Redefine the ADC Landscape
In a move that signals a significant shift in the oncology therapeutic pipeline, global manufacturing powerhouse Lonza has entered into...
Unlocking the "Cholesterol Trap": New Biological Pathway Offers Hope for Treatment-Resistant Heart Disease
Despite decades of medical advancement and the widespread use of statins and PCSK9 inhibitors, cardiovascular disease (CVD) remains the leading...
California’s Life Sciences Sector: Resilience Amidst a Protracted "Biotech Winter"
Executive Summary: A Powerhouse at a Crossroads California remains the undisputed global epicenter for biotechnology and life sciences innovation, yet...
The Twilight of a Pioneer: Sangamo Therapeutics Files for Chapter 11 Bankruptcy
In a somber turn of events for the biotechnology sector, Sangamo Therapeutics—a Bay Area-based company that effectively birthed the field...
